BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31128609)

  • 1. Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia.
    Shioya S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Senoo T; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2019 Jun; 152():44-50. PubMed ID: 31128609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
    Yura H; Sakamoto N; Satoh M; Ishimoto H; Hanaka T; Ito C; Hasegawa T; Tanaka S; Miyamura T; Nakashima S; Hara A; Kakugawa T; Oda K; Kido T; Obase Y; Ishimatsu Y; Yatera K; Kawakami A; Mukae H
    Respir Med; 2017 Nov; 132():189-194. PubMed ID: 29229096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.
    Takato H; Waseda Y; Watanabe S; Inuzuka K; Katayama N; Ichikawa Y; Yasui M; Fujimura M
    Respir Med; 2013 Jan; 107(1):128-33. PubMed ID: 23137883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific interstitial pneumonia (NSIP) associated with anti-KS antibody: differentiation from idiopathic NSIP.
    Okayasu K; Ohtani Y; Takemura T; Uchibori K; Tamaoka M; Furuiye M; Miyazaki Y; Inase N; Yoshizawa Y
    Intern Med; 2009; 48(15):1301-6. PubMed ID: 19652435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies.
    Yamakawa H; Hagiwara E; Kitamura H; Iwasawa T; Otoshi R; Aiko N; Katano T; Shintani R; Ikeda S; Okuda R; Sekine A; Baba T; Iso S; Kuwano K; Sato S; Ogura T
    Respiration; 2018; 96(3):210-221. PubMed ID: 29768275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
    PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
    Chartrand S; Swigris JJ; Stanchev L; Lee JS; Brown KK; Fischer A
    Respir Med; 2016 Oct; 119():150-154. PubMed ID: 27692137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.
    Koreeda Y; Higashimoto I; Yamamoto M; Takahashi M; Kaji K; Fujimoto M; Kuwana M; Fukuda Y
    Intern Med; 2010; 49(5):361-9. PubMed ID: 20190466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of Autoantibodies against the Golgi Complex and Ro52 Antigen in a Patient with Nonspecific Interstitial Pneumonia.
    Andrejevic S; Milenkovic B; Stojsic J; Stevic R; Bonaci-Nikolic B
    Intern Med; 2016; 55(3):273-8. PubMed ID: 26831023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
    BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ and CD8+ T lymphocytes in lung tissue of NSIP: correlation with T lymphocytes in BALF.
    Qin L; Wang WZ; Liu HR; Xu WB; Qin MW; Zhang ZH; Xiao Y; Zhen WJ; Shi JH
    Respir Med; 2013 Jan; 107(1):120-7. PubMed ID: 23085212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
    Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of idiopathic nonspecific interstitial pneumonia.
    Poletti V; Romagnoli M; Piciucchi S; Chilosi M
    Semin Respir Crit Care Med; 2012 Oct; 33(5):440-9. PubMed ID: 23001799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X; Zhang L; Jin Q; Lu X; Lei J; Peng Q; Wang G; Ge Y
    Front Immunol; 2022; 13():987841. PubMed ID: 36110863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of bronchoalveolar lavage fluids from nonspecific interstitial pneumonia and from ordinary interstitial pneumonia].
    Sakamoto N; Mukae H; Kakugawa T; Nagata T; Kaida H; Ishii H; Abe K; Kadota J; Matsukura S; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 2002 Jul; 40(7):564-8. PubMed ID: 12382419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune pulmonary alveolar proteinosis exacerbated by steroid therapy due to misdiagnosis as anti-aminoacyl-tRNA synthetase (ARS) antibody positive- interstitial pneumonia: a case report.
    Ishimoto H; Sakamoto N; Yura H; Hara A; Kido T; Yamaguchi H; Yamamoto K; Obase Y; Ishimatsu Y; Satoh M; Mukae H
    BMC Pulm Med; 2022 Mar; 22(1):120. PubMed ID: 35361191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.
    Isoda K; Kotani T; Takeuchi T; Kiboshi T; Hata K; Ishida T; Otani K; Kamimori T; Fujiwara H; Shoda T; Makino S
    Rheumatol Int; 2017 Aug; 37(8):1335-1340. PubMed ID: 28451794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.